NCT06681246View on ClinicalTrials.gov

The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 11, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions
ObesityWeight Loss
Interventions
OTHER

Antibiotic treatment

10 days of either antibiotics- Augmentin (amoxicillin+clauvonate), 875mg, 2 /day

OTHER

Placebo

consist of a combination of agarose in normal saline/glycerol

Trial Locations (1)

Unknown

RECRUITING

Weizmann Institute of Science, Rehovot

All Listed Sponsors
collaborator

Hadassah Medical Organization

OTHER

lead

Weizmann Institute of Science

OTHER